Autologous stem cell transplant in lymphoma using a noncryopreserved platform: an adapted sequential conditioning maintaining dose intensity does not affect transplantation outcomes.
In this study, we show our experience.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Sarmiento M, Rojas P, Gutierrez C, Quezada J, Jara V, Campbell J, Garcia MJ, Sandoval V, Vergara M, Triantafilo N, Ocqueteau M Source Type: research
More News: Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants